Evidence map›Paper›PMID 32813868›Full record

ArticleRevista de saude publica2020

Effectiveness of adherence to a renal health program in a health network in Peru.

Jessica Bravo-Zúñiga, Enrique M Saldarriaga, Ricardo Chávez-Gómez, Jungmei Gálvez-Inga, Renzo Valdivia-Vega, Mirko Villavicencio-Carranza, José Espejo-Sotelo, Carola Medina-Sal Y Rosas, Víctor Suarez-Moreno, Yamilee Hurtado-Roca

Open access · goldAbstract read
In one paragraph

Article in Revista de saude publica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Jessica Bravo-ZúñigaDepartamento de Nefrología, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.
Enrique M SaldarriagaInstituto de Evaluación de Tecnologías en Salud e Investigación, EsSalud, Lima, Perú.
Ricardo Chávez-GómezDepartamento de Nefrología, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.
Jungmei Gálvez-IngaDepartamento de Nefrología, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.
Renzo Valdivia-VegaDepartamento de Nefrología, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.
Mirko Villavicencio-CarranzaDepartamento de Nefrología, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.
José Espejo-SoteloDepartamento de Nefrología, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.
Carola Medina-Sal Y RosasDepartamento de Nefrología, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.
Víctor Suarez-MorenoInstituto de Evaluación de Tecnologías en Salud e Investigación, EsSalud, Lima, Perú.
Yamilee Hurtado-RocaInstituto de Evaluación de Tecnologías en Salud e Investigación, EsSalud, Lima, Perú.
Hospital Nacional Cayetano Heredia · PEEsSALUD · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

OBJECTIVE To evaluate the effectiveness of adherence to a multidisciplinary renal health program in reducing mortality and progression to hemodialysis. METHODS We used a database that included patient monitoring (2013-2017), dialysis admissions and all cause of mortality in Peru. Adherence to the program was established by meeting minimum visits during the first year of monitoring. The outcome of interest was hemodialysis admissions or all cause-mortality. Kaplan-Meier curves, Log-Rank test and competing survival analysis methods were used to estimate the differential risk between adherent and non-adherent patients. RESULTS A total of 20,354 participants was evaluated; 54.1% were male, 72.1 years old in average, 2.2 years average follow-up, and 15,279 (75.1%) belonged to the early stages (1 to 3a) of Chronic Kidney Disease. Adherence decreased the risk of renal replacement therapy in 41.0% (HR = 0.59, 95%CI 0.41-0.85) in the low-risk group and mortality in the high-risk group was 31.0% (HR = 0.69, 95%CI 0.57-0.83). CONCLUSIONS The multidisciplinary care strategy with standardized assessments by stage is effective in reducing admission to .0when the patient is identified in early stages and in reducing mortality in advanced stages.

Indexed as

Guideline AdherenceAgedAged, 80 and overFemaleHumansKaplan-Meier EstimateKidney Failure, ChronicMaleOutcome and Process Assessment, Health CarePeruProgram EvaluationRenal DialysisRenal Insufficiency, ChronicRenal Replacement TherapyRisk FactorsSurvival Analysis

Identifiers

PMID32813868
PMCPMC7416761
OpenAlexW3048863996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.